Janney Montgomery Scott
SBBP

Janney Montgomery Scott’s Strongbridge Biopharma plc. SBBP Stock Holding History

Janney Montgomery Scott’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-16,500
Closed -$39K – 2159
2019
Q3 		$39K Hold
16,500
– – ﹤0.01% 2025
2019
Q2 		$52K Buy
16,500
+1,000
+6% +$3.67K ﹤0.01% 2017
2019
Q1 		$77K Buy
15,500
+1,500
+11% +$7.39K ﹤0.01% 1962
2018
Q4 		$63K Buy
14,000
+2,000
+17% +$9.76K ﹤0.01% 1900
2018
Q3 		$58K Buy
+12,000
New +$61.4K ﹤0.01% 2020

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Janney Montgomery Scott's SBBP Position: Q4 2019 in Review

Janney Montgomery Scott sold out of Strongbridge Biopharma plc. (SBBP) in Q4 2019, closing a stake of 16,500 shares — an estimated $39K sold.

Janney Montgomery Scott first reported a position in SBBP in Q3 2018 and held it in 5 quarters. The position peaked at $77K in Q1 2019. 58 funds tracked by Wall St. Rank hold SBBP as of Q4 2019.

  • Janney Montgomery Scott reported no remaining Strongbridge Biopharma plc. position as of Q4 2019 after selling out during the quarter.
  • Janney Montgomery Scott sold 16,500 Strongbridge Biopharma plc. shares in Q4 2019, an estimated $39K.
  • Janney Montgomery Scott first reported a position in Strongbridge Biopharma plc. in Q3 2018 and held it in 5 quarters.
  • Janney Montgomery Scott's Strongbridge Biopharma plc. position peaked at $77K in Q1 2019.
  • 58 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2019.

Based on Janney Montgomery Scott's 13F filing for Q4 2019, filed 21 Jan 2020.